CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 1964 Oct 1

PMID 14213477

Citations 14

Authors

D A CURRAN

J W Lance

Affiliations

Soon will be listed here.

Citing Articles

Migraine, Allergy, and Histamine: Is There a Link?.

Ferretti A, Gatto M, Velardi M, Di Nardo G, Foiadelli T, Terrin G J Clin Med. 2023; 12(10).

PMID: 37240671 PMC: 10218803. DOI: 10.3390/jcm12103566.

Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR.

Jamu I, Okamoto H Front Glob Womens Health. 2023; 3:1012463.

PMID: 36619589 PMC: 9812521. DOI: 10.3389/fgwh.2022.1012463.

Histamine and migraine revisited: mechanisms and possible drug targets.

Worm J, Falkenberg K, Olesen J J Headache Pain. 2019; 20(1):30.

PMID: 30909864 PMC: 6734463. DOI: 10.1186/s10194-019-0984-1.

Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and α-agonists.

DAndrea G, Bussone G, Di Fiore P, Perini F, Gucciardi A, Bolner A Neurol Sci. 2017; 38(Suppl 1):37-43.

PMID: 28527056 DOI: 10.1007/s10072-017-2862-4.

Tryptamine levels are low in plasma of chronic migraine and chronic tension-type headache.

DAndrea G, DAmico D, Bussone G, Bolner A, Aguggia M, Saracco M Neurol Sci. 2014; 35(12):1941-5.

PMID: 25016960 DOI: 10.1007/s10072-014-1867-5.

References

FRIEDMAN A . Treatment of headache with reserpine. Neurology. 1955; 5(11):805-8. DOI: 10.1212/wnl.5.11.805. View

Dalessio D, CAMP W, GOODELL H, Wolff H . Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type. Arch Neurol. 1961; 4:235-40. DOI: 10.1001/archneur.1961.00450090001001. View

DALSGAARD-NIELSEN T . [On the prophylactic treatment of migraine with deseril]. Praxis. 1960; 49:867-8. View

FRIEDMAN A, LOSIN S . Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide). Arch Neurol. 1961; 4:241-5. DOI: 10.1001/archneur.1961.00450090007002. View

KIMBALL R, FRIEDMAN A, Vallejo E . Effect of serotonin in migraine patients. Neurology. 1960; 10:107-11. DOI: 10.1212/wnl.10.2.107. View

TUNIS M, Wolff H . Analysis of cranial artery pulse waves in patients with vascular headache of the migraine type. Am J Med Sci. 1952; 224(5):565-8. DOI: 10.1097/00000441-195211000-00013. View

HEYCK H . [Serotonin antagonists in the therapy of migraine and Bing's erythroprosopalgia or the Horton syndrome]. Schweiz Med Wochenschr. 1960; 90:203-9. View

HAVERBACK B, DUTCHER T, Shore P, TOMICH E, Terry L, Brodie B . Serotonin changes in platelets and brain induced by small daily doses of reserpine; lack of effect of depletion of platelet serotonin on hemostatic mechanisms. N Engl J Med. 1957; 256(8):343-5. DOI: 10.1056/NEJM195702212560804. View

SICUTERI F . Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine. Int Arch Allergy Appl Immunol. 1959; 15:300-7. DOI: 10.1159/000229055. View

10.

Elkind A, FRIEDMAN A, Grossman J . CUTANEOUS BLOOD FLOW IN VASCULAR HEADACHES OF THE MIGRAINE TYPE. Neurology. 1964; 14:24-30. DOI: 10.1212/wnl.14.1.24. View

11.

SOUTHERN A, CHRISTOFF N . Cerebrospinal fluid serotonin in brain tumor and other neurological disorders determined by a spectrophotofluorometric technique. J Lab Clin Med. 1962; 59:320-6. View

12.

Southwell N, Williams J, Mackenzie I . METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE. Lancet. 1964; 1(7332):523-4. DOI: 10.1016/s0140-6736(64)92910-1. View

13.

Harris M . Prophylactic treatment of migraine headache and histamine cephalalgia with a serotonin antagonist (methysergide). Ann Allergy. 1961; 19:500-4. View

14.

OSTFELD A, Reis D, GOODELL H, Wolff H . Headache and hydration; the significance of two varieties of fluid accumulation in patients with vascular headache of the migraine type. AMA Arch Intern Med. 1955; 96(2):142-52. DOI: 10.1001/archinte.1955.00250130016002. View

15.

Graham J . Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache. N Engl J Med. 1960; 263:1273-7. DOI: 10.1056/NEJM196012222632502. View

16.

Lance J, FINE R, CURRAN D . An evaluation of methysergide in the prevention of migraine and other vascular headaches. Med J Aust. 1963; 50(1):814-8. View

17.

Hale A, Reed A . Prophylaxis of frequent vascular headache with methysergide. Am J Med Sci. 1962; 243:92-8. DOI: 10.1097/00000441-196201000-00014. View

18.

ROOKE E, Rushton J, Peters G . Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide). Proc Staff Meet Mayo Clin. 1962; 37:433-43. View

19.

Selby G, Lance J . Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960; 23:23-32. PMC: 495326. DOI: 10.1136/jnnp.23.1.23. View

20.

Wolff H . Headache mechanisms. Int Arch Allergy Appl Immunol. 1955; 7(4-6):210-78. DOI: 10.1159/000228230. View